send mail to support@abhimanu.com mentioning your email id and mobileno registered with us! if details not recieved
Resend Opt after 60 Sec.
By Loging in you agree to Terms of Services and Privacy Policy
Claim your free MCQ
Please specify
Sorry for the inconvenience but we’re performing some maintenance at the moment. Website can be slow during this phase..
Please verify your mobile number
Login not allowed, Please logout from existing browser
Please update your name
Subscribe to Notifications
Stay updated with the latest Current affairs and other important updates regarding video Lectures, Test Schedules, live sessions etc..
Your Free user account at abhipedia has been created.
Remember, success is a journey, not a destination. Stay motivated and keep moving forward!
Refer & Earn
Enquire Now
My Abhipedia Earning
Kindly Login to view your earning
Support
Type your modal answer and submitt for approval
With reference to ‘FAITH’ trials, consider following statements
Select the correct statement.
1 only
2 only
Both
None
With the number of COVID-19 patients rising in India, Glenmark Pharmaceuticals Ltd. will conduct ‘FAITH’ trials to test combined efficacy of two antiviral drugs — Favipiravir and Umifenovir — as potential COVID-19 treatment strategy. The two antiviral drugs have different mechanisms of action, and their combination may demonstrate improved treatment efficacy by effectively tackling high viral loads in patients during early stages of the disease. The new combination clinical trial will be called FAITH – (FA vipiravir plus Um I fenovir (efficacy and safety) Trial in Indian Hospital setting). As many as 158 hospitalised patients of moderate COVID-19 infection will be enrolled in the combination study and randomised in two groups. Hence both statements are correct.
By: Shubham Tiwari ProfileResourcesReport error
Access to prime resources
New Courses